CARBAMAZEPINE ER
Generic: CARBAMAZEPINE
Oryza Pharmaceuticals Inc.Manufacturer
ORALRoute
CARBAMAZEPINEActive Substance
2021-09-30Original Approval
CARBAMAZEPINE ER is FDA application ANDA212948, sponsored by ANBISON LAB. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
3,503 reports
2
DRUG INTERACTION
2,442 reports
3
TOXICITY TO VARIOUS AGENTS
2,284 reports
4
SEIZURE
1,968 reports
5
OFF LABEL USE
1,859 reports
6
FALL
1,856 reports
7
DIZZINESS
1,494 reports
8
FATIGUE
1,386 reports
9
PAIN
1,386 reports
10
PYREXIA
1,368 reports